In contrast, in a study conducted by Jung et al., therapy with macrophages overexpressing the anti-inflammatory factor- interleukin IL-10 had a positive effect on reducing the local inflammatory profile, with a concomitant increase in the expression of pro-regenerative lipocalin-2, protecting against acute kidney injury [47]. The gene discussed is LCN2; the disease is acute kidney injury.